|
Training set (n=162) |
Testing set (n=176) |
P-value |
|
CRC (n=55) |
Non-CRC (n=107) |
P-value |
CRC (n=56) |
Non-CRC (n=120) |
P-value |
Cases |
Controls |
Age, yr (S.E.) |
66.47 (1.50) |
68.31 (1.12) |
0.335 |
67.38 (1.83) |
69.99 (1.03) |
0.216 |
0.704 |
0.270 |
Gender, no. (%)
Male
Female |
32 (58.2)
23 (41.8) |
58(54.2)
49(45.8) |
0.630 |
28 (50.0)
28 (50.0) |
73 (60.8)
47 (39.2) |
0.176 |
0.387 |
0.313 |
Stage, no. (%)
I
II
III
IV |
21 (38.2)
10 (18.2)
14 (25.5)
10 (18.2) |
-
-
-
- |
- |
15 (26.8)
9 (16.1)
21 (37.5)
11 (19.6) |
-
-
-
- |
- |
0.447 |
- |
Tumor site, no. (%)
Colon
Rectum
Cecum
Colon+Rectum |
28 (50.9)
22 (40.0)
4 (7.3)
1 (1.8) |
- |
- |
30 (53.6)
16 (28.6)
5 (8.9)
5 (8.9) |
- |
- |
0.286 |
- |
CRC: ColonRectal Cancer; *Data are given as means (SE) or as the number of cases (%); §P values were estimated using the t-test